The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tikka, T. M.
Right arrow Articles by Koistinaho, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tikka, T. M.
Right arrow Articles by Koistinaho, J. E.
The Journal of Immunology, 2001, 166: 7527-7533.
Copyright © 2001 by The American Association of Immunologists

Minocycline Provides Neuroprotection Against N-Methyl-D-aspartate Neurotoxicity by Inhibiting Microglia1

Tiina M. Tikka* and Jari E. Koistinaho2,*,{dagger}

* A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland; and {dagger} Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland

Glutamate excitotoxicity to a large extent is mediated through activation of the N-methyl-D-aspartate (NMDA)-gated ion channels in several neurodegenerative diseases and ischemic stroke. Minocycline, a tetracycline derivative with antiinflammatory effects, inhibits IL-1{beta}-converting enzyme and inducible nitric oxide synthase up-regulation in animal models of ischemic stroke and Huntington’s disease and is therapeutic in these disease animal models. Here we report that nanomolar concentrations of minocycline protect neurons in mixed spinal cord cultures against NMDA excitotoxicity. NMDA treatment alone induced microglial proliferation, which preceded neuronal death, and administration of extra microglial cells on top of these cultures enhanced the NMDA neurotoxicity. Minocycline inhibited all these responses to NMDA. Minocycline also prevented the NMDA-induced proliferation of microglial cells and the increased release of IL-1{beta} and nitric oxide in pure microglia cultures. Finally, minocycline inhibited the NMDA-induced activation of p38 mitogen-activated protein kinase (MAPK) in microglial cells, and a specific p38 MAPK inhibitor, but not a p44/42 MAPK inhibitor, reduced the NMDA toxicity. Together, these results suggest that microglial activation contributes to NMDA excitotoxicity and that minocycline, a tetracycline derivative, represents a potential therapeutic agent for brain diseases.




This article has been cited by other articles:


Home page
 BrainHome page
M. Politis, N. Pavese, Y. F. Tai, S. J. Tabrizi, R. A. Barker, and P. Piccini
Hypothalamic involvement in Huntington's disease: an in vivo PET study
Brain, November 1, 2008; 131(11): 2860 - 2869.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Latremoliere, A. Mauborgne, J. Masson, S. Bourgoin, V. Kayser, M. Hamon, and M. Pohl
Differential Implication of Proinflammatory Cytokine Interleukin-6 in the Development of Cephalic versus Extracephalic Neuropathic Pain in Rats
J. Neurosci., August 20, 2008; 28(34): 8489 - 8501.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K. Hayakawa, K. Mishima, M. Nozako, M. Hazekawa, S. Mishima, M. Fujioka, K. Orito, N. Egashira, K. Iwasaki, and M. Fujiwara
Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1-Inhibiting Mechanism
Stroke, March 1, 2008; 39(3): 951 - 958.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
A. Vojdani, F. Hebroni, Y. Raphael, J. Erde, and B. Raxlen
Novel Diagnosis of Lyme Disease: Potential for CAM Intervention
Evid. Based Complement. Altern. Med., October 15, 2007; (2007) nem138v1.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Y. Lampl, M. Boaz, R. Gilad, M. Lorberboym, R. Dabby, A. Rapoport, M. Anca-Hershkowitz, and M. Sadeh
Minocycline treatment in acute stroke: An open-label, evaluator-blinded study
Neurology, October 2, 2007; 69(14): 1404 - 1410.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Kielian, N. Esen, S. Liu, N. K. Phulwani, M. M. Syed, N. Phillips, K. Nishina, A. L. Cheung, J. D. Schwartzman, and J. J. Ruhe
Minocycline Modulates Neuroinflammation Independently of Its Antimicrobial Activity in Staphylococcus aureus-Induced Brain Abscess
Am. J. Pathol., October 1, 2007; 171(4): 1199 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. Y. Yune, J. Y. Lee, G. Y. Jung, S. J. Kim, M. H. Jiang, Y. C. Kim, Y. J. Oh, G. J. Markelonis, and T. H. Oh
Minocycline Alleviates Death of Oligodendrocytes by Inhibiting Pro-Nerve Growth Factor Production in Microglia after Spinal Cord Injury
J. Neurosci., July 18, 2007; 27(29): 7751 - 7761.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
Y. F. Tai, N. Pavese, A. Gerhard, S. J. Tabrizi, R. A. Barker, D. J. Brooks, and P. Piccini
Microglial activation in presymptomatic Huntington's disease gene carriers
Brain, July 1, 2007; 130(7): 1759 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Nikodemova, J. J. Watters, S. J. Jackson, S. K. Yang, and I. D. Duncan
Minocycline Down-regulates MHC II Expression in Microglia and Macrophages through Inhibition of IRF-1 and Protein Kinase C (PKC){alpha}/betaII
J. Biol. Chem., May 18, 2007; 282(20): 15208 - 15216.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. M. Hamby, S. W. Suh, T. M. Kauppinen, and R. A. Swanson
Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion
Stroke, February 1, 2007; 38(2): 632 - 636.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. Nakazawa, C. Nakazawa, A. Matsubara, K. Noda, T. Hisatomi, H. She, N. Michaud, A. Hafezi-Moghadam, J. W. Miller, and L. I. Benowitz
Tumor Necrosis Factor-{alpha} Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma
J. Neurosci., December 6, 2006; 26(49): 12633 - 12641.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Franciosi, J. K. Ryu, H. B. Choi, L. Radov, S. U. Kim, and J. G. McLarnon
Broad-Spectrum Effects of 4-Aminopyridine to Modulate Amyloid beta1-42-Induced Cell Signaling and Functional Responses in Human Microglia.
J. Neurosci., November 8, 2006; 26(45): 11652 - 11664.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. C. Alano, T. M. Kauppinen, A. V. Valls, and R. A. Swanson
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations
PNAS, June 20, 2006; 103(25): 9685 - 9690.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Malm, M. Ort, L. Tahtivaara, N. Jukarainen, G. Goldsteins, J. Puolivali, A. Nurmi, R. Pussinen, T. Ahtoniemi, T.-K. Miettinen, et al.
beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits
PNAS, June 6, 2006; 103(23): 8852 - 8857.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
H. Levkovitch-Verbin, M. Kalev-Landoy, Z. Habot-Wilner, and S. Melamed
Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection.
Arch Ophthalmol, April 1, 2006; 124(4): 520 - 526.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. A. Yenari, L. Xu, X. N. Tang, Y. Qiao, and R. G. Giffard
Microglia Potentiate Damage to Blood-Brain Barrier Constituents: Improvement by Minocycline In Vivo and In Vitro
Stroke, April 1, 2006; 37(4): 1087 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
D. P. Stirling, K. M. Koochesfahani, J. D. Steeves, and W. Tetzlaff
Minocycline as a Neuroprotective Agent
Neuroscientist, August 1, 2005; 11(4): 308 - 322.
[Abstract] [PDF]

Home page
 J. Leukoc. Biol.Home page
F. Giuliani, W. Hader, and V. W. Yong
Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction
J. Leukoc. Biol., July 1, 2005; 78(1): 135 - 143.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. M. Kauppinen and R. A. Swanson
Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death
J. Immunol., February 15, 2005; 174(4): 2288 - 2296.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore, W. H. Baldridge, G. M. Seigel, and M. E. M. Kelly
An Investigation of the Neuroprotective Effects of Tetracycline Derivatives in Experimental Models of Retinal Cell Death
Mol. Pharmacol., November 1, 2004; 66(5): 1113 - 1122.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson
Role of Microglia in Central Nervous System Infections
Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal., September 28, 2004; 2004(252): re14 - re14.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Darman, S. Backovic, S. Dike, N. J. Maragakis, C. Krishnan, J. D. Rothstein, D. N. Irani, and D. A. Kerr
Viral-Induced Spinal Motor Neuron Death Is Non-Cell-Autonomous and Involves Glutamate Excitotoxicity
J. Neurosci., August 25, 2004; 24(34): 7566 - 7575.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Zhang, B. Lei, T. T. Lam, F. Yang, D. Sinha, and M. O. M. Tso
Neuroprotection of Photoreceptors by Minocycline in Light-Induced Retinal Degeneration
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2753 - 2759.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wang, Q. Wei, C.-Y. Wang, W. D. Hill, D. C. Hess, and Z. Dong
Minocycline Up-regulates Bcl-2 and Protects against Cell Death in Mitochondria
J. Biol. Chem., May 7, 2004; 279(19): 19948 - 19954.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. P. Stirling, K. Khodarahmi, J. Liu, L. T. McPhail, C. B. McBride, J. D. Steeves, M. S. Ramer, and W. Tetzlaff
Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury
J. Neurosci., March 3, 2004; 24(9): 2182 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. D. Teng, H. Choi, R. C. Onario, S. Zhu, F. C. Desilets, S. Lan, E. J. Woodard, E. Y. Snyder, M. E. Eichler, and R. M. Friedlander
Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury
PNAS, March 2, 2004; 101(9): 3071 - 3076.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. Diguet, C. E. Gross, E. Bezard, F. Tison, N. Stefanova, G. K. Wenning, B. Ravina, S. Fagan, R. Hart, C. Hovinga, et al.
Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment
Neurology, January 13, 2004; 62(1): 158 - 159.
[Full Text] [PDF]

Home page
 J PsychopharmacolHome page
R. M. Bonelli and H.-P. Kapfhammer
Why Minocycline is Helpful in Huntington's Disease
J Psychopharmacol, December 1, 2003; 17(4): 461 - 461.
[PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Raghavendra, F. Tanga, and J. A. DeLeo
Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 624 - 630.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. M. Friedlander
Apoptosis and Caspases in Neurodegenerative Diseases
N. Engl. J. Med., April 3, 2003; 348(14): 1365 - 1375.
[Full Text] [PDF]

Home page
 NeurologyHome page
R. M. Bonelli, C. Heuberger, and F. Reisecker
Minocycline for Huntington's disease: An open label study
Neurology, March 11, 2003; 60(5): 883 - 884.
[Full Text] [PDF]

Home page
 BrainHome page
T. M. Tikka, N. E. Vartiainen, G. Goldsteins, S. S. Oja, P. M. Andersen, S. L. Marklund, and J. Koistinaho
Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease
Brain, April 1, 2002; 125(4): 722 - 731.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. C. Wu, V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, D.-K. Choi, H. Ischiropoulos, and S. Przedborski
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
J. Neurosci., March 1, 2002; 22(5): 1763 - 1771.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Du, Z. Ma, S. Lin, R. C. Dodel, F. Gao, K. R. Bales, L. C. Triarhou, E. Chernet, K. W. Perry, D. L. G. Nelson, et al.
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
PNAS, November 20, 2001; (2001) 251341998.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Du, Z. Ma, S. Lin, R. C. Dodel, F. Gao, K. R. Bales, L. C. Triarhou, E. Chernet, K. W. Perry, D. L. G. Nelson, et al.
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
PNAS, December 4, 2001; 98(25): 14669 - 14674.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.